| Mr John R Phoenix, APRN | |
|
1830 E Sahara Ave, Suite 201, Las Vegas, NV 89104 | |
| (702) 979-1111 | |
| (702) 979-6228 |
| Full Name | Mr John R Phoenix |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 1830 E Sahara Ave, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013289024 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APRN001359 (Nevada) | Primary |
| 363LF0000X | Nurse Practitioner - Family | APN001359 (Nevada) | Secondary |
| Entity Name | John Phoenix,aprn,pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134553068 PECOS PAC ID: 7113154980 Enrollment ID: O20131226001407 |
News Archive
meridianEMR, Inc., a leading provider of electronic health records systems and advanced healthcare analytics for urology and surgical practices, today has announced the launch of its exclusive multi-dimensional clinical analysis tool – UROAnalytics.
Health insurance premiums increased at the slowest pace in eight years, marking the fourth consecutive year premium increases have declined, according to a new report released today.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has identified a third microRNA target in its alliance with GlaxoSmithKline (GSK), triggering a preclinical milestone payment from GSK.
The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.
› Verified 3 days ago
| Entity Name | Superior Emergency Physicians Harris, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356885222 PECOS PAC ID: 9739461252 Enrollment ID: O20170118001297 |
News Archive
meridianEMR, Inc., a leading provider of electronic health records systems and advanced healthcare analytics for urology and surgical practices, today has announced the launch of its exclusive multi-dimensional clinical analysis tool – UROAnalytics.
Health insurance premiums increased at the slowest pace in eight years, marking the fourth consecutive year premium increases have declined, according to a new report released today.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has identified a third microRNA target in its alliance with GlaxoSmithKline (GSK), triggering a preclinical milestone payment from GSK.
The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr John R Phoenix, APRN 1830 E. Sahara Ave, Suite 201, Las Vegas, NV 89104 Ph: (702) 979-1111 | Mr John R Phoenix, APRN 1830 E Sahara Ave, Suite 201, Las Vegas, NV 89104 Ph: (702) 979-1111 |
News Archive
meridianEMR, Inc., a leading provider of electronic health records systems and advanced healthcare analytics for urology and surgical practices, today has announced the launch of its exclusive multi-dimensional clinical analysis tool – UROAnalytics.
Health insurance premiums increased at the slowest pace in eight years, marking the fourth consecutive year premium increases have declined, according to a new report released today.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has identified a third microRNA target in its alliance with GlaxoSmithKline (GSK), triggering a preclinical milestone payment from GSK.
The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.
› Verified 3 days ago
Dena Kae Meeter, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7455 W Washington Ave, #160, Las Vegas, NV 89128 Phone: 702-878-0393 Fax: 702-940-5601 | |
Ms. Lotis Gay Perilla Edano, APRN, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169 Phone: 702-732-2438 Fax: 702-733-7876 | |
Jann Stacey Pickens, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-4506 Fax: 702-388-4810 | |
Tamaris Samantha Cotta, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9280 W Sunset Rd Ste 400, Las Vegas, NV 89148 Phone: 702-366-1268 Fax: 702-366-7079 | |
Tasha Gouin, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9097 W Post Rd Ste 100, Las Vegas, NV 89148 Phone: 702-430-5333 | |
Aric Pedro Adaoag, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9816 Gilespie St Ste 550, Las Vegas, NV 89183 Phone: 702-202-6336 Fax: 702-202-6318 | |
Ms. Michele Marie Brock, NURSE PRACTITIONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5380 S Rainbow Blvd Ste 120, Las Vegas, NV 89118 Phone: 702-463-4040 |